INTRODUCTION
An elevated level of low-density lipoproteins (LDL) is a known risk factor for atherosclerosis, as most of the intracellular lipid accumulating in macrophages beneath the endothelium is thought to be derived from LDL, and formation of lipid-laden macrophages (or foam cells) is an important and early event in atherogenesis [1, 2] . Cellular uptake of LDL particles normally occurs via the LDL-receptor pathway, which is tightly controlled in a way that does not allow formation of foam cells [1] . However, after certain types of modification, high-uptake forms of LDL are generated that can lead to foam-cell formation [3] . Despite much research, the precise nature, origin and site of production of the responsible modifying agent(s) remain unknown.
Monocytes/macrophages are thought to be important in the development of atheroscelerosis, because they are present in large numbers in fatty steaks and early and late lesions, and may modify LDL to a high-uptake form in vivo. Formation of lipid hydroperoxides is generally assumed to represent the initial step and to be a prerequisite for oxidative modification of LDL in vivo and in vitro [3] . In fact, many groups use lipid (per)oxidation almost exclusively as the index of oxidative LDL modification. It has been shown by studies in vitro that various cells, including monocytes and macrophages, are capable of (per)oxidizing LDL lipids via radical reactions. These reactions appear to be dependent on transition metals, whether present in the media [4] or added by other means [5] , although it is by no means certain that amounts of lipid hydroperoxides, chlorohydrins, cholesterol or fatty acid oxidation products formed. Treatment with -OC1 caused aggregation of LDL, as shown by an increased turbidity of the oxidized LDL solution and elution from a size-exclusion h.p.l.c. column of high-molecular-mass LDL complexes. Chemical modification of lysine residues before oxidation with -OC1 prevented aggregation, while it enhanced the extent of lipid peroxidation. Treatment of LDL with -OC1 also caused the formation of carbonyl groups and release of ammonia; both these modifications were inhibited by lysine-residue modification before oxidation. These results demonstrate that aggregation reactions are dependent on initial lysine oxidation by -OC1, followed by deamination and carbonyl formation, but do not involve lipid (per)oxidation. We propose that the observed -OC1-mediated aggregation of LDL is caused, at least in part, by crosslinking of apoproteins by Schiff-base formation independently of lipid peroxidation.
such high concentrations of metal would be available in vivo. Modifications independent of lipid peroxidation have received little attention, although enzymes such as lipases [6] , sphingomyelinase [7] and macrophage proteases [8] , as well as physical aggregation [9] , can modify LDL in a way that it causes lipid uptake by macrophages.
Upon appropriate stimulation, monocytes can release large amounts of myeloperoxidase (MPO, EC 1.11.1.7) into the extracellular space [10, 11] , although they lose this ability as they differentiate into macrophages [11] . MPO reacts with H202 to form, initially and transiently, compound I, which itself can react with Cl-ions to form hypochlorite (-OC1) [12] or, depending on the availability of substrates, participate in one-electron reactions [13, 14] . Thus MPO plus H202 can oxidize many different compounds, including proteins, lipids, nucleotides and antioxidants.
During our survey of the effect of different physiological oxidants on the early stages of LDL oxidation, we observed that exposure to reagent -C1 transformed the lipoprotein into a form which caused extensive lipid accumulation in macrophages [15] . We observed immediate and almost exclusive modification of the protein, whereas only small amounts of hydroperoxides of cholesteryl ester (CEOOH) and phospholipids were formed, suggesting that -C1 reacted with protein in preference to lipid. The results of the present study demonstrate that, in addition to CEOOH, neither cholesterol oxidation products nor chlorohydrins were major products of LDL oxidation by -0C1. We also observed that treatment of LDL with -OC1 resulted in lipoprotein Abbreviations used: apo, apolipoprotein; CEOOH, cholesteryl ester hydroperoxides; DNPH, 2,4-dinitrophenylhydrazine; LDL, low-density lipoproteins; MPO, myeloperoxidase; -OCI, sodium hypochlorite or hypochlorous acid, since a mixture of these two species is present at pH 7.4.
$ To whom correspondence should be addressed. aggregation, carbonyl formation and release of ammonia. Because all of these processes were inhibited by modification of the lysine residues before oxidation, aggregation of LDL by -OCI requires lysine-residue modification, and this is likely to involve Schiff-base formation, potentially giving rise to apoprotein crosslinks.
MATERIALS AND METHODS Materials
Nanopure water was used for all buffers and aqueous solutions, which were subsequently treated with Chelex-100 (Bio-Rad) to remove contaminating transition metals. Heparinized Vacutainers were obtained from Becton-Dickson; bicinchoninic acid, fluorescamine, 5,5'-dithiobis-(2-nitrobenzoic acid), methionine, 2,4-dinitrophenzylhydrazine (DNPH), phospholipase A2 (from pig pancreas), cholesterol esterase from Sigma, and reagent -OC1 (5 % available chlorine minimum) from Aldrich. Phosphate (50 mM)-buffered saline (PBS) was used, with EDTA (0.1 %, w/v) for LDL isolation and without EDTA for gel filtration and resuspension of the lipoprotein. Organic solvents were of h.p.l.c. quality (Mallinckrodt) or the highest grade available. MPO [purity index = 0.75 (A430/A280)] was kindly provided by Dr. Anthony Kettle, Christchurch School of Medicine, Christchurch, New Zealand. The concentration of H202 was determined by its absorbance (6240 = 43.6 M-' cm-') [16] .
LDL preparation and oxidation
Blood was obtained freshly from non-fasted healthy normolipidaemic male or female subjects (23-35 years old) and drawn into heparinized Vacutainers. LDL was isolated from plasma by ultracentrifugation by a rapid analytical method (2 h, 15°C) [17] and gel-filtered (PD-10 column, Pharmacia), and its protein concentration was determined [18] with BSA (Sigma Diagnostics) as standard.
'Bolus oxidation' with reagent -OC1 was carried out on ice and at final pH 7.4 by addition of 1 vol. of reagent -OC1, freshly diluted in phosphate buffer (50 mM), to 4 vol. of LDL solution (final concn. 0.5-2.0 mg of protein/ml). The concentration of the total amount of oxidizing equivalents present in the diluted commercial -OC1 solution was determined as described previously [15] . After addition of -OC, the reaction mixture was mixed briefly (< 1 s) and left on ice for 15 30 min at 37°C and then acidified to pH 2.0 with HCI and extracted with 4 x 2 ml of dichloromethane. The combined dichloromethane (8 ml) containing fatty acids and cholesterol was washed with 0.1 M HCI (2 ml) and then evaporated, redissolved in methanol, sealed under N2 and kept at -80°C until derivative formation. Production of derivatives of the samples and g.l.c./m.s. analyses of cholesterol oxidation products, fatty acid chlorohydrins and other fatty acid oxidation products were carried out as described previously [19] .
Quantification and modification of amino acid residues Unmodified lysine and tryptophan residues in LDL were quantified as described in [15] . Reductive methylation was carried out in 50 mM phosphate buffer, pH 9.0, as described previously [20] . Briefly, isolated LDL (1-2 mg/ml) was transferred to this buffer by gel-filtration and divided into three portions: control (no additions), reduced (NaBH4 only), and reduced and methylated (additions of NaBH4 and formaldehyde). NaBH4 (final concn. approx. 1 mg/mg of LDL) was added in two or three aliquots before and part way through the addition of a large number of small aliquots of formaldehyde (6 M, total amount -1 x I05 mol of formaldehyde/mol of LDL) with 5 min between additions. Samples were acidified to pH 5.0 and then separately gel-filtered into PBS, pH 7.4. This treatment resulted in modification of 70-90 % of apo B's lysine residues. After protein determination, the variously modified samples were adjusted to the same protein concentration and divided into smaller aliquots before being oxidized with bolus -OC1.
To determine carbonyl groups, control, reduced and reduced plus methylated LDL samples were oxidized (final concn. 1.6 ,M apo B-100) before an equal volume of DNPH (1 mM in 1 M HCI) was added. After incubation for 30 min at 50°C, 1.5 vol. of 1 M NaOH was added and the A450 was measured. An average molar absorption coefficient of 22000 M-l cm-' was used to estimate the carbonyl content [21] . For ammonia determination, the treated and oxidized samples were incubated at 37°C for 2 h before an excess of methionine was added to each sample. Free ammonia concentrations were then measured with a RAICHEM kit (Baxter Diagnostics).
Alterations to LDL particles
Changes in surface charge of LDL were measured by agarose-gel electrophoresis [15] . LDL aggregation was determined by either h.p.l.c. gel filtration or turbidity measurements. H.p.l.c. was carried out on a LKB Ultropac TSK G4000SW column (60 cm x 0.75 cm) with a guard column (0.7 cm x 7.5 cm; SW Progel-TSK) eluted with PBS, pH 7.4, at 0.5 ml/min [22] and monitored at 210 or 280 nm. For turbidity, the A680 of the treated CEOOH and lipid-soluble antioxidants (ubiquinol-1O, a-toco-and oxidized samples was measured. (5a-cholesten-3,f-ol); 2, 6fi-hydroxycholesterol (4-cholestene-3,f,6,#-diol) ( -OCI with LDL. These results do not exclude the possibility that lipid-oxidation products other than lipid hydroperoxides are formed. Of particular interest are fatty acid chlorohydrins, which are known to be formed when isolated fatty acids or phospholipids are treated with hypochlorite [19, 24] . However, g.l.c./m.s. analysis of the lipids from -OCI-treated LDL showed no detectable chlorohydrins, even when a high ratio of 1000 -OC1/LDL was used (Figure 2 ). If more than 0. [19, 24] . Although g.l.c./m.s. is able to detect a number of fatty acid oxidation products, including fatty acid epoxides, hydroxy and dihydroxy derivatives, at concentrations lower than 10 nM, none of these was present in -OCI-oxidized LDL. We have shown previously that amino acid residues of apo B-100, particularly lysine, quantitatively represent LDL's major target for oxidation by reagent -OC1 [15] . Figure 3 Samples were oxidized by the bolus method, separated by h.p.l.c. gel filtration (see the Materials and methods section) and the eluate was monitored at 210 nm. Qualitatively similar results were obtained when the eluate was monitored at 280 nm. The peak eluted at -55 min (c) represents methionine, present in the low-molecular-mass fraction. The aggregation with -CI was repeated four times, and the de-aggregation with methionine was repeated twice. All repetitions gave similar results with LDL from different donors.
the variation between the reagent and enzyme treatments. Also, no lag phase in the loss of lysine and tryptophan residues was observed, indicating no antioxidant protection or preferential oxidation of another target. Thus the lysine residues of apo B-100 represent the major single target in LDL for -OCI, independent of whether reagent or enzymically produced oxidant is used. We concluded that reagent -OCI was a suitable 'model' for MPO/H202/Cl-oxidation of LDL, in agreement with a previous report [25] , and used the former for all subsequent experiments.
Oxidation of LDL with -OCI results in formation of a 'highuptake' LDL [15] , i.e. a form of LDL that, when exposed to macrophages, causes intracellular accumulation of lipids. Several types of modification of LDL can cause such an effect, including a wide variety of lysine-or arginine-modifying reagents [26, 27] and lipoprotein aggregation [7, 9] . Exposure of LDL to increasing amounts of -OCI gave rise to higher-molecular-mass aggregates of increasing size, absorbing at 210 nm (Figure 4 ). Thus at 600 -OCI/LDL most of the LDL was eluted with the void volume of the gel-filtration column (Figure 4c ), whereas at 300 -OCI/LDL (Figure 4b) different columns of the same gel type, and was the result of -OC1 treatment of LDL, as it was not observed after multiple (> 50) injections of native LDL, high-density lipoprotein or very-lowdensity lipoprotein (results not shown). Owing to the high costs associated with regular replacement of the h.p.l.c. columns, we therefore assessed LDL aggregation by turbidity measurement, as done previously by others [9] . Figure 5 shows that treatment of control LDL with -OC1 resulted in a concentration-dependent increase in turbidity. In contrast, LDL whose lysine residues were reductively methylated before exposure to -OC1 did not aggregate, as indicated by a lack of increase in turbidity. The lack of aggregation was not due to some conformational or chemical changes caused by the NaBH4 reduction that precedes methylation, since samples treated with NaBH4 but not formaldehyde aggregated in the same way upon -OC1 oxidation as did untreated LDL. These results demonstrated that -OCI-mediated modification of apo B's lysine residues was required for the observed oxidant-induced aggregation of LDL.
Although reductive methylation of apo B's lysine residues strongly decreased the extent of -OC-mediated aggregation of -OCI oxidation of reductively methylated LDL resulted in significantly higher rates of both formation of CEOOH ( Table 2) and consumption of lipid-soluble antioxidants ( Figure 6 ). This provided direct evidence that peroxidative modification of LDL's lipids was not involved in -OC1-mediated aggregation of the lipoprotein. Rather, the protein appeared to protect the lipid and lipophilic antioxidants from oxidation by -OCl. The cause of the variation between LDL samples (Table 2) is not known. Oxidation of amines has been suggested to produce aldehydes that may cause cross-linking [28] through reaction with an eamino group (to form a Schiff base) or other residues (such as histidine). To assess aldehyde formation, we measured carbonyl groups in control and -OCI-treated LDL and found their content to increase with increasing oxidant concentration (Figure 7a ). The amounts of carbonyl groups detected corresponded to -170% of the chloramines formed. Carbonyl formation was inhibited partially by reductive methylation of LDL before oxidation, suggesting that some carbonyl groups of the reductively methylated LDL did not originate from lysine residues. Lipid peroxidation products could contribute to these non-lysine-derived carbonyl groups, as they are produced in increased amounts in reductively methylated LDL (Table 2) and can give rise to aldehydes.
Incubation of -OCI-oxidized LDL at 37°C resulted in a concentration-dependent formation of ammonia (Figure 7b ) that was inhibited completely by reductive methylation of LDL before its oxidation. The absolute amount of carbonyls and ammonia measured differ quantitatively. This may be due to the lipophilic and volatile nature of ammonia or to the formation of additional carbonyl groups during the assay procedure.
DISCUSSION
In biological systems, -OC1 is produced from H202 and Cl-via the action of MPO with the initial formation of compound I. The latter can undergo one-electron redox reactions and hence could conceivably initiate lipid peroxidation. Consistent with this, we observed larger amounts of CEOOH when LDL was oxidized with MPO/H202/Cl-rather than reagent -OC1. Also, the formation of CEOOH by enzymically generated -OC1 was not dependent on Cl-, suggesting a direct reaction of LDL with compound I rather than an indirect effect mediated via -OC1. It has recently been shown that horseradish peroxidase treatment of LDL results in increased TBARS (thiobarbituric acid-reacting substances) values [29] . It is difficult to compare this with our results, because it is not possible to relate the TBARS value obtained to an actual CEOOH concentration, since little qualitative or quantitative relationship exists between TBARS values and CEOOH concentration [30] .
CEOOH represent the major single class of lipid hydroperoxides in radical-oxidized human LDL [31] . The h.p.l.c.-chemiluminescence method that we used is both highly sensitive (detection limit in the low nM range) and very specific for CEOOH [17] . Although an increase in temperature or using MPO rather than reagent -OCI during oxidation both increased the production of CEOOH slightly, it is still a reaction of minor quantitative importance. -OCI and MPO can oxidize isolated non-esterified fatty acids and phospholipids to chlorohydrins [19, 24] . However, even at high concentrations of this oxidant, chlorohydrins, fatty acid oxidation products or cholesterol oxidation products were not formed in substantial amounts in LDL (Figure 2) . Together, these results demonstrate that LDL lipid oxidation in general does not appear to be important with this oxidant. In contrast with LDL's lipids, modification of the lipoprotein's lysine and tryptophan residues quantitatively represented major reactions ( [15] ; Figure 3 of the present paper). Since modification of these two residues was not different with the two -OCI systems, we conclude that oxidation of LDL by reagent -OCI is a good model for the oxidation mediated by MPO/H202/Cl-.
The apparent absence of substantial amounts of lipid hydroperoxides in -OCl-treated LDL is consistent with observations by Arnhold et al. [32] . Also, Carlin and Djursater [33] found that while MPO could peroxidize phospholipids in the presence of bromide, physiological concentrations of NaCl completely inhibited this peroxidation. On the other hand, Stelmaszynska et al. [34] reported a large degree of lipid peroxidation upon treatment of LDL with MPO/H202/Cl-, as assessed by the A234. These authors carried out the oxidation at pH 6.0, in the presence of EDTA with large amounts of MPO and a high final concentration of oxidant produced (corresponding to -1000 -OCI/LDL). However, when using reagent -OCI at the same high ratio of oxidant to LDL and under the experimental conditions described above, we failed to observe a significant increase in A234 (L. J. Hazell and R. Stocker, unpublished work). MPO, used to produce half the mole ratio of oxidant to LDL used by Stelmaszynska et al. [34] , produced peroxidation of 1 to produce higher concentrations of oxidant, because of limited availability of the enzyme. The reason for the apparent disparity in results remains uncertain, although our results using several independent and specific methods for the analysis of lipidoxidation products argue strongly against their importance in the initial stages of -OCI oxidation of LDL. In fact, our results suggest that apo B-100 protects the lipids from oxidative attack by this oxidant. This is supported directly by the fact that reductive methylation of the lysine residues increases the extent of both lipid peroxidation ( Table 2 ) and consumption of antioxidants ( Figure 6 ).
Treatment of LDL with reagent -OCI caused the lipoprotein to aggregate (Figures 4 and 5) . That aggregation can be reversed by methionine and, to a lesser extent, lysine, or inhibited by reductive methylation of LDL's lysine residues, suggests that chloramines are likely to be required for this process. This, together with our findings of -OCI-mediated formation of chloramines [15] , aldehydes and ammonia (Figure 7) , and that all of these processes were inhibited by reductive methylation of the apo B's lysine residues before oxidation, is consistent with the following sequence of reactions leading to LDL aggregates:
The (Figure 7) , consistent with the reported extent of chloramine loss during storage of -OC-oxidized LDL [15] . Our proposed scheme receives additional support from work published by others. Thus oxidation of human lipoprotein (a) and LDL by reagent -OC1 has been shown to cause formation of non-disulphide cross-linked high-molecular-mass apo B species detected by SDS/PAGE [37] . Other proteins are also crosslinked by exposure to either reagent or enzymically produced -OC1 [38, 39] , as are low-molecular-mass amines to proteins [40] . Furthermore, oxidation of elastin by -OC1 caused loss of 3H from the c-carbon of lysine residues [28] . Together, these findings suggest that -OCI/MPO-mediated cross-linking of LDL represents a feasible mechanism by which this lipoprotein may be transformed into an atherogenic form. Other mechanisms are also possible. Thus, in the presence of free tyrosine [14, 41] or catechol [41] , MPO/H202 may cross-link proteins via bityrosine formation, in the former, or via reactions involving o-quinone, in the latter.
Schiff-base-type modification has also been suggested to occur in LDL oxidized by transition-metal-dependent radical reactions, lipid hydroperoxides. This raises the possibility that the material reported in human plaque or in the circulation of patients with atherosclerosis that cross-reacted with antibodies raised against aldehyde-modified LDL (see, e.g. [42, 43] ) may have in part derived from -OC1-modified LDL.
The formation of LDL aggregates by -OC1 may have several effects relevant to atherosclerosis. Aggregates of LDL, in general, cause lipid loading in macrophages in vitro [6, 7, 9] , and we have observed that -OC1-modified LDL also causes foam-cell formation [15] . Furthermore, cross-linked LDL (copper-oxidized, 4-hydroxynonenal-or myricetin-treated), once internalized by macrophages, is more resistant to degradation [44] , therefore potentially amplifying its atherogenic properties. [45] , or required large amounts of bound or free transition metals in the media [5, 46] to obtain large amounts of oxidized lipids. Our studies show that, under conditions that resemble the physiological situation, -OC1 oxidizes LDL to a high-uptake form for macrophages without extensive lipid oxidation. These studies warrant further investigation of the possible presence in human plaque of MPO-and -OC1-modified LDL.
